An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Publication Information
Authors
Tooley James E., Herold Kevan C.
Studies
Abstract
Biomarkers of type 1 diabetes are important for assessing risk of developing disease, monitoring disease progression, and determining responses to clinical treatments. Here we review recent advances in the development of biomarkers of type 1 diabetes with a focus on their utility in clinical trials.